GSTC (GlobeStar Therapeutics) OCF Margin %: 0.00% (As of Jun. 2024)


What is GlobeStar Therapeutics OCF Margin %?

GlobeStar Therapeutics GSTC -99.00% OCF Margin % is 0.00% as of Jun. 2024.

OCF Margin % is calculated as Cash Flow from Operations divided by its Revenue. GlobeStar Therapeutics's Cash Flow from Operations for the three months ended in Jun. 2024 was $-0.02 Mil. GlobeStar Therapeutics's Revenue for the three months ended in Jun. 2024 was $0.00 Mil. Therefore, GlobeStar Therapeutics's OCF Margin % for the quarter that ended in Jun. 2024 was 0.00%.

As of today, GlobeStar Therapeutics's current OCF Yield % is 0.00%.

The historical rank and industry rank for GlobeStar Therapeutics's OCF Margin % or its related term are showing as below:


GSTC's OCF Margin % is not ranked *
in the Biotechnology industry.
Industry Median: -68.59
* Ranked among companies with meaningful OCF Margin % only.

GlobeStar Therapeutics OCF Margin % Related Terms

GlobeStar Therapeutics OCF Margin % Historical Data

* Premium members only.

The historical data trend for GlobeStar Therapeutics's OCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

GlobeStar Therapeutics OCF Margin % Chart

GlobeStar Therapeutics Annual Data
Trend Sep14 Sep15 Sep16 Sep17 Sep18 Sep19 Sep20 Sep21 Sep22 Sep23
OCF Margin %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

GlobeStar Therapeutics Quarterly Data
Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24
OCF Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

GlobeStar Therapeutics OCF Margin % Calculation

OCF Margin % is the ratio of Cash Flow from Operations divided by net sales or Revenue, usually presented in percent.

GlobeStar Therapeutics's OCF Margin for the fiscal year that ended in Sep. 2023 is calculated as

OCF Margin=Cash Flow from Operations (A: Sep. 2023 )/Revenue (A: Sep. 2023 )
=-0.206/0
= %

GlobeStar Therapeutics's OCF Margin for the quarter that ended in Jun. 2024 is calculated as

OCF Margin=Cash Flow from Operations (Q: Jun. 2024 )/Revenue (Q: Jun. 2024 )
=-0.02/0
= %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about OCF Margin % →
What does a OCF Margin % of 0.00% mean?
GlobeStar Therapeutics (GSTC) has a OCF Margin % of 0.00% as of Jun. 2024. OCF Margin is the ratio of Cash Flow from Operations to Total Revenue. View historical data on GlobeStar Therapeutics and its competitors.
Is GlobeStar Therapeutics' OCF Margin % too high?
GlobeStar Therapeutics' current OCF Margin % is 0.00%.
How does GlobeStar Therapeutics' OCF Margin % compare to GBLX and ENDV?
GlobeStar Therapeutics' OCF Margin % of 0.00% can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good OCF Margin % for a Biotechnology company?
A good OCF Margin % depends on the Biotechnology industry context. However, OCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high OCF Margin % mean?
A high OCF Margin % can signal that a stock is expensive relative to its fundamentals. OCF Margin is the ratio of Cash Flow from Operations to Total Revenue. View historical data on GlobeStar Therapeutics and its competitors. GlobeStar Therapeutics's current OCF Margin % is 0.00%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is GlobeStar Therapeutics stock overvalued right now?
GlobeStar Therapeutics (GSTC) has a current OCF Margin % of 0.00%. The current OCF Margin % is 0.00%. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is OCF Margin % calculated?
OCF Margin % is calculated from a company's financial statements. For GlobeStar Therapeutics (GSTC), the current OCF Margin % is 0.00% as of Jun. 2024. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

GlobeStar Therapeutics Business Description

Address 719 Jadewin Avenue, Richland, WA, USA, 99352
GlobeStar Therapeutics Corp is a clinical-stage pharmaceutical company introducing a patented formulation of previously approved drugs for the treatment of Multiple Sclerosis. The company is focused on developing therapies for people with serious and life-threatening rare disorders.